Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Gloria Hernández‐Torres, Mariateresa Cipriano, Erika Hedén, et al.
Angewandte Chemie (2014) Vol. 126, Iss. 50, pp. 13985-13990
Closed Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs—A practical view
Christopher J. Fowler
European Neuropsychopharmacology (2015) Vol. 25, Iss. 6, pp. 749-762
Closed Access | Times Cited: 47
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Andrea Manterola, Ana Bernal‐Chico, Raffaela Cipriani, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 189-201
Open Access | Times Cited: 42
In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies
Ran Cheng, Wakana Mori, Longle Ma, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 6, pp. 2278-2291
Open Access | Times Cited: 41
A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia
Nagore I. Marín‐Ramos, Moisés Balabasquer, Francisco J. Ortega-Nogales, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6035-6046
Open Access | Times Cited: 40
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis
Leyre Mestre, Francisco Carrillo‐Salinas, Míriam Mecha, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 51-66
Closed Access | Times Cited: 39
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Carlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112857-112857
Open Access | Times Cited: 34
The endocannabinoid system – current implications for drug development
Christopher J. Fowler
Journal of Internal Medicine (2020) Vol. 290, Iss. 1, pp. 2-26
Open Access | Times Cited: 34
Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Narjes Shahsavani, Hardeep Kataria, Soheila Karimi‐Abdolrezaee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 6, pp. 166117-166117
Closed Access | Times Cited: 30
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety
Shuhei Ikeda, Hideyuki Sugiyama, Hidekazu Tokuhara, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11014-11044
Open Access | Times Cited: 28
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Gareth Pryce, David Baker
Handbook of experimental pharmacology (2015), pp. 213-231
Closed Access | Times Cited: 36
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
Giulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 817-836
Open Access | Times Cited: 34
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 2, pp. 153-168
Closed Access | Times Cited: 31
Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis
Inés Reynoso-Moreno, Silvia Tietz, Erika Vallini, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 765-779
Open Access | Times Cited: 25
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome
Beatriz Marcos‐Ramiro, Ana Gil-Ordóñez, Nagore I. Marín‐Ramos, et al.
ACS Central Science (2021) Vol. 7, Iss. 8, pp. 1300-1310
Open Access | Times Cited: 25
Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets
Giulia Palermo, Inga Bauer, Pablo Campomanes, et al.
PLoS Computational Biology (2015) Vol. 11, Iss. 6, pp. e1004231-e1004231
Open Access | Times Cited: 33
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
Carlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2017) Vol. 32, Iss. 1, pp. 1240-1252
Open Access | Times Cited: 31
A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells
Mar Martín‐Fontecha, Alba Angelina, Beate Rückert, et al.
Bioconjugate Chemistry (2018) Vol. 29, Iss. 2, pp. 382-389
Closed Access | Times Cited: 30
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Andrea Chicca, Chiara Arena, Clementina Manera
Recent Patents on CNS Drug Discovery (2016) Vol. 10, Iss. 2, pp. 122-141
Open Access | Times Cited: 28
Synthesis and preclinical evaluation of [ 11 C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)
Muneer Ahamed, Bala Attili, Daisy van Veghel, et al.
European Journal of Medicinal Chemistry (2017) Vol. 136, pp. 104-113
Open Access | Times Cited: 27
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
Freek J. Janssen, Mario van der Stelt
Bioorganic & Medicinal Chemistry Letters (2016) Vol. 26, Iss. 16, pp. 3831-3837
Open Access | Times Cited: 26
Loratadine analogues as MAGL inhibitors
Jayendra Z. Patel, Stephen Ahenkorah, Miia Vaara, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 7, pp. 1436-1442
Closed Access | Times Cited: 25
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment
Mónica Tapia, Ana Lucía Dominguez, Wei Zhang, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 25
Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT1A Receptor in Native Cells of the Immune System
Gloria Hernández‐Torres, Ernesto Enríquez-Palacios, Míriam Mecha, et al.
Bioconjugate Chemistry (2018) Vol. 29, Iss. 6, pp. 2021-2027
Closed Access | Times Cited: 25

Scroll to top